The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.
Early adoption of multiple practice affiliations signals this trend "will become the norm rather than an exception," experts write in the Journal of the American College of Radiology.
Indiana University radiologist Richard B. Gunderman, MD, PhD, shared the story of an anonymous colleague's moral distress, hoping to humanize this issue.
Governor Gavin Newsom has until Sept. 30 to sign or veto the bill, which gives the attorney general oversight over private equity buyouts in healthcare.
The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.